Table 4.
p value | Odds ratio | 95% CI | ||
---|---|---|---|---|
MRI referral | noMRI | Reference | – | – |
Screening MRI | 0.452 | 0.8 | 0.4–1.5 | |
Diagnostic MRI | 0.029 | 0.7 | 0.5–1.0 | |
Preoperative MRI | < 0.001 | 0.7 | 0.6–0.8 | |
Hormonal status | Postmenopausal | Reference | – | – |
Premenopausal | 0.021 | 0.8 | 0.6–1.0 | |
Perimenopausal | 0.246 | 0.8 | 0.6–1.1 | |
Lesion focus at US | No observable lesion | Reference | – | – |
Single focus | 0.016 | 0.8 | 0.6–1.0 | |
Multifocal | 0.069 | 0.7 | 0.5–1.0 | |
Multicentric | 0.029 | 0.4 | 0.2–0.9 | |
Largest lesion diameter at US | ≥ 20 mm | 0.029 | 0.8 | 0.6–1.0 |
Surgical pathology | Pure DCIS | < 0.001 | 2.5 | 1.9–3.3 |
DCIS associated to invasive cancer | < 0.001 | 1.8 | 1.4–2.2 | |
Largest lesion diameter ≥ 20 mm | < 0.001 | 1.5 | 1.2–1.8 | |
Multifocal or multicentric cancer | 0.001 | 1.5 | 1.2–1.9 | |
Lobular component | 0.017 | 1.4 | 1.1–1.8 |
CI, confidence interval; US, ultrasonography; MRI, magnetic resonance imaging; DCIS, ductal carcinoma in situ